';
Authors Posts by Cathy Barrick

Cathy Barrick

314 POSTS 0 COMMENTS

Tablet on a desk - Newsletter

The Office of Developmental Programs (ODP) has released bulletin ODPANN 24-083. This communication is to announce the release of the latest issue of the CI Spotlight, which can be found on the Certified Investigator Program Home Page. This edition of the CI Program Spotlight includes articles on interviewing people who don’t communicate in universally understood ways, Temple University’s CI Peer Reviews, and more.

If you have a suggestion for a future Spotlight article, please visit here to submit your suggestion.

Photo by Alena Shekhovtcova from Pexels

The FDA has approved and authorized for emergency use updated COVID-19 vaccines (2024-2025 formula) that include a monovalent (single) component that corresponds to the omicron variant KP.2 strain of SARS-CoV-2. These vaccines were updated to provide better protection against COVID-19 caused by circulating variants. Two vaccines are available for use in the United States: 2024–2025 Moderna COVID-19 Vaccine and 2024–2025 Pfizer-BioNTech COVID-19 Vaccine. There is no preference for one vaccine over the other when more than one vaccine is recommended for an age group

Who should get the vaccine?

Everyone ages 6 months and older should get the 2024–2025 COVID-19 vaccine. This includes people who have received a COVID-19 vaccine before and people who have had COVID-19. The COVID-19 vaccine helps protect you from severe disease, hospitalization, and death.

It is especially important to get your 2024–2025 COVID-19 vaccine if you are:

  • Ages 65 and older,
  • At high risk for severe COVID-19
  • Have never received a COVID-19 vaccine.
  • Are living in a long-term care facility
  • Are pregnant, breastfeeding, trying to get pregnant, or might become pregnant in the future.
  • Want to lower your risk of getting Long COVID

People who recently had COVID-19:

  • People who recently had COVID-19 may delay getting a COVID-19 vaccine for 3 months.
  • The risk of getting COVID-19 is less likely in the weeks to months following a SARS-CoV-2 infection.

Certain factors could be reasons to get a vaccine sooner rather than later, such as:

  • Personal risk of severe COVID-19
  • Risk of COVID-19 in a family or household member or other close contact
  • local levels of COVID-19 illness

Keep in mind‎:

  • Vaccine protection decreases over time, so it is important to stay up to date with your COVID-19 vaccine.
  • Getting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19.

ANCOR is working in partnership with the State of the States in Intellectual and Developmental Disabilities Project of National Significance at the University of Kansas to evaluate promising practices and strategies to enhance technology use by people with I/DD across the US and the landscape of access resulting from flexibilities provided during the COVID-19 pandemic.

It is essential that ANCOR drives a high response rate to ensure they capture a full picture of what providers are doing and experiencing in the field. Please help them not only get the word out, but also encourage your members to participate! Take the survey here.

But wait! There’s more… ANCOR will also be offering a sneak peek at the results during their upcoming Tech Summit on October 29! After that, the full report will be released by the University of Kansas, which they will share, as well.

The Quality Management (QM) Data Collection Tool for CPS and Day Habilitation now has a short tutorial video available on the CPS resource page on the MyODP website. You can view it here.

In addition, an unprotected version of the tool is available due to multiple requests. Please be aware that using the unprotected version could inadvertently change the formulas when editing other cells, meaning the formulas could display incorrect calculations or an error.

The Office of Developmental Programs (ODP) has shared ODPANN 24-082. The announcement advises providers of the availability of the Incident Management (IM) Overview Dashboard to Assess Performance-Based Contracting (PBC) Measures RM-IM.01.2, .01.3, and .01.4 Guide on MyODP. Please view the announcement for information on the guide and how to access it.

The Office of Developmental Programs (ODP) has shared an update to bulletin ODPANN 24-025. ODP has received accreditation for designated MyODP trainings that meet requirements towards the National Association of Direct Support Professionals (NADSP) E-Badge Academy. Changes to the original announcement have been made in red. You can view the accredited training list here.

Photo by Christina @ wocintechchat.com on Unsplash

Adult Autism Waiver (AAW) and Adult Community Autism Program (ACAP) providers are invited to sign up for a scheduled one-on-one virtual office hour (VOH) session to discuss IM topics with the Office of Developmental Programs’ Bureau of Services for Autism and Special Populations (ODP-BSASP).

Providers may sign up for one 30-minute session, and multiple staff from the provider may join at the provider’s discretion.

Topics for discussion may include provider-specific IM issues or concerns; Enterprise Incident Management (EIM) reports; general questions about certified investigations; brainstorming ideas of how to improve “performance” related IM tasks; reviewing of provider IM data and compliance; discussion of provider trends; etc.

We encourage AAW providers and ACAP to take advantage of this opportunity. Sessions are offered in 30-minutes intervals and are on a first-come, first-served basis.

Thursday, September 19, 2024
First scheduled session begins at 8:30 am
Register here

Please be sure to complete all required information to reserve a time slot. Please contact the Provider Support Inbox with questions.

The Department of Human Services (DHS) released the following Medical Assistance (MA) Bulletin on Friday, August 23, 2024:

In addition, an updated version of the ODP Electronic Visit Verification (EVV) Technical Guide can be found below. This updated guide includes essential information on the latest compliance requirements and procedures:

Agencies are encouraged to review these documents thoroughly to ensure compliance and that provider policy and procedures are aligned with the updated requirements.

Thank you for your continued commitment to providing high-quality services for individuals with Intellectual Disabilities and Autism (ID/A) and their families in Pennsylvania.